{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:39:09Z","timestamp":1775576349294,"version":"3.50.1"},"reference-count":32,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"published-print":{"date-parts":[[2003,3]]},"abstract":"<jats:p>BACKGROUND: Many of the currently used Helicobacter pylori eradication regimens fail to cure the infection due to either antimicrobial resistance or poor patient compliance. Those patients will remain at risk of developing potentially severe complications of peptic ulcer disease. AIM: We studied the impact of the antimicrobial resistance on the efficacy of a short course pantoprazole based triple therapy in a single-center pilot study. METHODS: Forty previously untreated adult patients (age range 20 to 75 years, 14 males) infected with Helicobacter pylori and with inactive or healing duodenal ulcer disease were assigned in this open cohort study to 1 week twice daily treatment with pantoprazole 40 mg, plus clarithromycin 250 mg and metronidazole 400 mg. Helicobacter pylori was assessed at entry and 50 \u00b1 3 days after the end of treatment by rapid urease test, culture and histology of gastric biopsies. The criteria for eradication was a negative result in the tests. Susceptibility of Helicobacter pylori to clarithromycin and metronidazole was determined before treatment with the disk diffusion test. RESULTS: One week treatment and follow up were complete in all patients. Eradication of Helicobacter pylori was achieved in 35\/40 patients (87.5%) and was higher in patients with nitroimidazole-susceptible strains [susceptible: 20\/20 (100%), resistant: 10\/15 (67%)]. There were six (15%) mild adverse events reports. CONCLUSIONS: A short course of pantoprazole-based triple therapy is well tolerated and effective in eradicating Helicobacter pylori. The baseline metronidazole resistance may be a significant limiting factor in treatment success.<\/jats:p>","DOI":"10.1590\/s0004-28032003000100012","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:20:40Z","timestamp":1113574840000},"page":"55-60","source":"Crossref","is-referenced-by-count":8,"title":["The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy"],"prefix":"10.1590","volume":"40","author":[{"given":"Jaime Natan","family":"Eisig","sequence":"first","affiliation":[{"name":"S\u00e3o PauloUniversity, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraia Boaventura","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"S\u00e3o PauloUniversity, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Marcuz","family":"Silva","sequence":"additional","affiliation":[{"name":"S\u00e3o PauloUniversity, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"S\u00e3o PauloUniversity, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim Prado Pinto","family":"Moraes-Filho","sequence":"additional","affiliation":[{"name":"S\u00e3o PauloUniversity, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Atilio","family":"Laudanna","sequence":"additional","affiliation":[{"name":"S\u00e3o PauloUniversity, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1572-0241.1998.459_a.x","article-title":"Cure of H. pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two week dual therapy","volume":"93","author":"Adamek JR","year":"1998","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00042737-199409000-00004","article-title":"Short-term low-dose triple therapy for the eradication of Helicobacter pylori","volume":"6","author":"Bazzoli F","year":"1994","journal-title":"Eur J Gastroenterol Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0954-691X","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2036.1992.tb00556.x","article-title":"Experience with triple anti-Helicobacter pylori eradication therapy: side-effects and the importance of testing the pre-treatment bacterial isolate for metronidazol resistance","volume":"4","author":"Bell GD","year":"1992","journal-title":"Aliment Pharmacol"},{"key":"ref4","first-page":"A118","article-title":"H. pylori eradication: high efficacy week treatment with clarithromycin 500 mg bid, amoxicilin 1,0 gr bid plus lansoprazole 30 mg bid in S\u00e3o Paulo, Brazil","volume":"94","author":"Chehter EZ","year":"1999","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref5","first-page":"A1367","article-title":"Low dose omeprazole + clarithromycin + metronidazole in the eradication of Helicobacter pylori: interim results","volume":"94","author":"Chiba N","year":"1994","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1523-5378.2000.00006.x","article-title":"pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration","volume":"5","author":"Dammann HG","year":"2000","journal-title":"Helicobacter","ISSN":"https:\/\/id.crossref.org\/issn\/1083-4389","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/003655299750025660","article-title":"Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication","volume":"34","author":"Ellenrieder V","year":"1999","journal-title":"Scand J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0036-5521","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.41.1.8","article-title":"Current European concepts in the management of Helicobacter pylori infection: The Maastricht Consensus Report","volume":"41","year":"1997","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref9","first-page":"1","article-title":"One-week low-dose triple therapy: new standards for Helicobacter pylori treatment","volume":"7","author":"Goddard A","year":"1995","journal-title":"Eur J Gastroenterol Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0954-691X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.1999.00555.x","article-title":"A systematic review of Helicobacter pylori eradication therapy the impact of antimicrobial resistance on eradication rates","volume":"13","author":"Houben MH","year":"1999","journal-title":"Aliment Pharmacol Ther","ISSN":"https:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2036.1999.00530.x","article-title":"The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole","volume":"13","author":"Huang J","year":"1999","journal-title":"Aliment Pharmacol Ther","ISSN":"https:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"},{"key":"ref12","first-page":"685","article-title":"Critical issues in the pathophysiology and management of peptic ulcer disease: Meeting report","volume":"7","author":"Hunt RH","year":"1995","journal-title":"Eur J Gastroenterol Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0954-691X","issn-type":"print"},{"key":"ref13","first-page":"943","article-title":"Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers","volume":"90","author":"Jaup BH","year":"1995","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref14","first-page":"122","article-title":"Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori","volume":"25","author":"Labenz J","year":"1995","journal-title":"Leber Magen Darm","ISSN":"https:\/\/id.crossref.org\/issn\/0300-8622","issn-type":"print"},{"key":"ref15","first-page":"9","article-title":"One-week low-dose triple therapy for the eradication of Helicobacter pylori infection","volume":"7","author":"Labenz J","year":"1995","journal-title":"Eur J Gastroenterol Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0954-691X","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study","volume":"1","author":"Lind T","year":"1996","journal-title":"Helicobacter","ISSN":"https:\/\/id.crossref.org\/issn\/1083-4389","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/00365529309098341","article-title":"Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment","volume":"28","author":"Malfertheiner P","year":"1993","journal-title":"Scand J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0036-5521","issn-type":"print"},{"key":"ref18","series-title":"Helicobacter pylori: Basic mechanism to clinical cure","first-page":"570","volume-title":"H. pylori resistance to antibiotics","author":"M\u00e9graud F.","year":"1994"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.43.11.2747","article-title":"Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study","volume":"43","author":"M\u00e9graud F","year":"1999","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1523-5378.2000.00011.x","article-title":"Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil","volume":"5","author":"Mendon\u00e7a S","year":"2000","journal-title":"Helicobacter","ISSN":"https:\/\/id.crossref.org\/issn\/1083-4389","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00313029700169415","article-title":"Antimicrobial resistance testing of Helicobacter pylori: a comparison of E-test and disk diffusion methods","volume":"29","author":"Midolo PD","year":"1997","journal-title":"Pathology","ISSN":"https:\/\/id.crossref.org\/issn\/0031-3025","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.41.6.735","article-title":"One-week triple therapy for Helicobacter pylori: a multicenter comparative study. Lansoprazole Helicobacter Study Group","volume":"41","author":"Misiewicz JJ","year":"1997","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref23","first-page":"A6","article-title":"Relevance of metronidazole resistance in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori","volume":"39","author":"Moayyedi P","year":"1996","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref24","series-title":"Acid related diseases: Biology and treatment","first-page":"345","volume-title":"Helicobacter pylori: Infection and its consequences","author":"Modlin IM","year":"1998"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"Helicobacter pylori in peptic ulcer disease: NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease","volume":"272","year":"1994","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref26","first-page":"1860","article-title":"Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double blind trial","volume":"88","author":"Peterson WL","year":"1993","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref27","first-page":"322","article-title":"Metronidazol resistant Helicobacter pylori in a developing country","volume":"88","author":"Queiroz DM","year":"1993","journal-title":"Am J Gastroenterol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9270","issn-type":"print"},{"key":"ref28","first-page":"275","article-title":"Pseudomembranous colitis following clarithromycin therapy","volume":"7","author":"Teare JP","year":"1995","journal-title":"Eur J Gastroenterol Hepatol","ISSN":"https:\/\/id.crossref.org\/issn\/0954-691X","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1523-5378.1997.tb00085.x","article-title":"Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin","volume":"2","author":"Tompkins DS","year":"1997","journal-title":"Helicobacter","ISSN":"https:\/\/id.crossref.org\/issn\/1083-4389","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/AAC.38.10.2357","article-title":"Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori","volume":"38","author":"Xia H","year":"1994","journal-title":"Antimicrob Agents Chemother","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"Suppl 1","key":"ref31","first-page":"A55","article-title":"Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori","volume":"37","author":"Xia HX","year":"1995","journal-title":"Gut","ISSN":"https:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.1995.tb00374.x","article-title":"Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection","volume":"9","author":"Yousfi MM","year":"1995","journal-title":"Aliment Pharmacol Ther","ISSN":"https:\/\/id.crossref.org\/issn\/0269-2813","issn-type":"print"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v40n1\/a12v40n1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T22:54:45Z","timestamp":1706136885000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032003000100012&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0004-28032003000100012"],"URL":"https:\/\/doi.org\/10.1590\/s0004-28032003000100012","relation":{},"ISSN":["0004-2803"],"issn-type":[{"value":"0004-2803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}